Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CoronaVac in Rheumatic Diseases and HIV
NCT04754698Phase 4Completed
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Feb 2021
- Primary completion
- Nov 2023
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of coronavac in coronavirus disease 2019 (COVID-19), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Started Feb 2021; status: completed.
02
Drugs
coronavac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04754698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04754698.